Fifth Third Bancorp’s holdings in Roivant Sciences were worth $37,000 as of its most recent filing with the SEC. Bank of New York Mellon Corp increased its holdings in shares of Roivant Sciences by 16.3% during the first quarter. Also, CEO Matthew Gline bought 3,315 shares of Roivant Sciences stock in a transaction on Thursday, September 18th. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report). Receive News & Ratings for Roivant Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roivant Sciences and related companies with MarketBeat.com's FREE daily email newsletter.